Q4 2017

Filed May 16, 2018 · 10-K · 105 days after period end · 0001697884-18-000009

Q4 2017 · 10-K

derived · Computed from the longer spans the company filed.

Revenue—

Net income—

EPS, diluted—Not derived. Share counts vary by quarter.

Operating Cash Flowderived$4,820—

Same quarter

no prior Q4 2016 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Jan 31, 2018 · filed May 16, 2018 · 105 d after period end

Vitaspring Biomedical Co. Ltd. · CIK 1697884 · Engraved from SEC EDGAR

VSBCVitaspring Biomedical Co. Ltd.